Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.17
Delayed Data
As of 11:29am ET
 +0.0623 / +0.77%
Today’s Change
5.70
Today|||52-Week Range
9.17
+33.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.00641.0K
 
 
Cost of Goods Sold0.000.000.00486.0K
 
 
Depreciation And Amortization5.4K6.0K4.0K4.0K
 
 
 
 
 
 
Operating ExpensesGross Income-5.4K-6.0K-4.0K151.0K
 
 
 
 
 
General Expenses4.3M6.3M7.4M10.2M
 
 
 
 
 
Research And Development2.3M3.7M4.8M7.7M
 
 
 
 
 
Total Operating Expenses4.3M6.3M7.4M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-6.3M-7.4M-10.0M
 
 
 
 
 
Extraordinary Credit44.7K--0.000.00
 
 
Interest Expense On Debt0.000.009.0K11.0K
 
 
 
Other Expenses-196.4K504.0K40.0K-82.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.4M-5.7M-7.2M-9.6M
 
 
 
 
 
Income Taxes-205.1K-4.0K-1.0K-1.3M
 
 
 
 
 
Net Income-4.2M-5.7M-7.2M-11.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.2M9.2M10.8M12.6M
 
 
 
 
 
Shares To Calculate EPS Diluted7.2M9.2M10.8M12.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.59-$0.62-$0.67-$0.87
 
 
 
 
 
EPS Diluted-$0.59-$0.62-$0.67-$0.87